drugset / Trial / NCT01694810
Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers
RandomizedParallel-groupSingle-blindTreatment
Summary
The study will assess safety and tolerability of different doses of topical gel containing a new chemical entity, NVN1000, and the vehicle (gel without drug) applied to the face of healthy volunteers with high counts of Propionibacterium acnes. The test product will be applied once daily for 4 weeks. Exploratory measures include whether the topical product decreases the amount of a bacteria associated with acne (P. acnes).
Timeline
- Start
- 2012-09
- Primary completion
- 2012-11
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BERDAZIMER SODIUM | Small molecule | 2 % | Topical |
| Subject | BERDAZIMER SODIUM | Small molecule | 4 % | Topical |
| Subject | BERDAZIMER SODIUM | Small molecule | 8 % | Topical |